Schechter Investment Advisors’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Schechter Investment Advisors’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,667	Closed	-$6.38K	–	694
2023 Q2	$6.38K	Hold	1,667	–	–	﹤0.01%	649
2023 Q1	$4.65K	Hold	1,667	–	–	﹤0.01%	683
2022 Q4	$4.48K	Hold	1,667	–	–	﹤0.01%	833
2022 Q3	$8K	Hold	1,667	–	–	﹤0.01%	930
2022 Q2	$18K	Hold	1,667	–	–	﹤0.01%	931
2022 Q1	$23K	Hold	1,667	–	–	﹤0.01%	917
2021 Q4	$40K	Buy	+1,667	New	+$39.3K	﹤0.01%	860

Other funds holding BTCY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return

AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Schechter Investment Advisors's BTCY Position: Q3 2023 in Review

Schechter Investment Advisors sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2023, closing a stake of 1,667 shares — an estimated $6.38K sold.

Schechter Investment Advisors first reported a position in BTCY in Q4 2021 and held it in 7 quarters. The position peaked at $40K in Q4 2021. 22 funds tracked by Wall St. Rank hold BTCY as of Q3 2023.

Schechter Investment Advisors reported no remaining Biotricity, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Schechter Investment Advisors sold 1,667 Biotricity, Inc. Common Stock shares in Q3 2023, an estimated $6.38K.
Schechter Investment Advisors first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Schechter Investment Advisors's Biotricity, Inc. Common Stock position peaked at $40K in Q4 2021.
22 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2023.

Based on Schechter Investment Advisors's 13F filing for Q3 2023, filed 6 Nov 2023.